The mydriatic effect of tropicamide and its diagnostic use in Alzheimer's disease
The mydriatic effect of topically administered tropicamide was investigated as a possible diagnostic indicator for Alzheimer's disease. Although an initial series seemed to show a correlation between hypersensitivity to tropicamide and intellectual impairment, subsequent testing showed a greate...
Gespeichert in:
| Veröffentlicht in: | Vision research (Oxford) 1997-01, Vol.37 (1), p.165-168 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 168 |
|---|---|
| container_issue | 1 |
| container_start_page | 165 |
| container_title | Vision research (Oxford) |
| container_volume | 37 |
| creator | Reitner, A Baumgartner, I Thuile, C Baradaran Dilmaghani, R Ergun, E Kaminski, S Lukas, J Dal Bianco, P |
| description | The mydriatic effect of topically administered tropicamide was investigated as a possible diagnostic indicator for Alzheimer's disease. Although an initial series seemed to show a correlation between hypersensitivity to tropicamide and intellectual impairment, subsequent testing showed a greater inter- and intra-individual variation than that between the normal group and the group of patients with intellectual impairment. This procedure seems, therefore, to lack sufficient specificity to be useful for such a diagnostic purpose. |
| doi_str_mv | 10.1016/s0042-6989(96)00119-8 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78888583</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78888583</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-5afa1146ade6c1c951fb696242c3ef9e9ba77aae4d3a13ea41577d3f90453bd73</originalsourceid><addsrcrecordid>eNo9kMtLAzEYxHNQaq3-CYWcfBxWk83mdSylPqAgQj0v3yZfbGQfdbN7qH-9LRbnMjDzYw5DyJyzB864ekyMFXmmrLF3Vt0zxrnNzBmZ_scX5DKlL8aYlrmdkIllyhhhpuR9s0Xa7H0fYYiOYgjoBtoFOvTdLjpookcKradxSNRH-Gy7dATHhDS2dFH_bDE22N8e24SQ8IqcB6gTXp98Rj6eVpvlS7Z-e35dLtaZE1IMmYQAnBcKPCrHnZU8VMqqvMidwGDRVqA1ABZeABcIBZdaexEsK6SovBYzcvO3u-u77xHTUDYxOaxraLEbU6nNQdKIAzg_gWPVoC93fWyg35enD8QvFKRd4Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78888583</pqid></control><display><type>article</type><title>The mydriatic effect of tropicamide and its diagnostic use in Alzheimer's disease</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Reitner, A ; Baumgartner, I ; Thuile, C ; Baradaran Dilmaghani, R ; Ergun, E ; Kaminski, S ; Lukas, J ; Dal Bianco, P</creator><creatorcontrib>Reitner, A ; Baumgartner, I ; Thuile, C ; Baradaran Dilmaghani, R ; Ergun, E ; Kaminski, S ; Lukas, J ; Dal Bianco, P</creatorcontrib><description>The mydriatic effect of topically administered tropicamide was investigated as a possible diagnostic indicator for Alzheimer's disease. Although an initial series seemed to show a correlation between hypersensitivity to tropicamide and intellectual impairment, subsequent testing showed a greater inter- and intra-individual variation than that between the normal group and the group of patients with intellectual impairment. This procedure seems, therefore, to lack sufficient specificity to be useful for such a diagnostic purpose.</description><identifier>ISSN: 0042-6989</identifier><identifier>DOI: 10.1016/s0042-6989(96)00119-8</identifier><identifier>PMID: 9068838</identifier><language>eng</language><publisher>England</publisher><subject>Aged ; Alzheimer Disease - diagnosis ; Cornea - physiology ; Female ; Humans ; Male ; Mydriatics - pharmacology ; Pupil - drug effects ; Reproducibility of Results ; Tropicamide - pharmacology</subject><ispartof>Vision research (Oxford), 1997-01, Vol.37 (1), p.165-168</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-5afa1146ade6c1c951fb696242c3ef9e9ba77aae4d3a13ea41577d3f90453bd73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9068838$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reitner, A</creatorcontrib><creatorcontrib>Baumgartner, I</creatorcontrib><creatorcontrib>Thuile, C</creatorcontrib><creatorcontrib>Baradaran Dilmaghani, R</creatorcontrib><creatorcontrib>Ergun, E</creatorcontrib><creatorcontrib>Kaminski, S</creatorcontrib><creatorcontrib>Lukas, J</creatorcontrib><creatorcontrib>Dal Bianco, P</creatorcontrib><title>The mydriatic effect of tropicamide and its diagnostic use in Alzheimer's disease</title><title>Vision research (Oxford)</title><addtitle>Vision Res</addtitle><description>The mydriatic effect of topically administered tropicamide was investigated as a possible diagnostic indicator for Alzheimer's disease. Although an initial series seemed to show a correlation between hypersensitivity to tropicamide and intellectual impairment, subsequent testing showed a greater inter- and intra-individual variation than that between the normal group and the group of patients with intellectual impairment. This procedure seems, therefore, to lack sufficient specificity to be useful for such a diagnostic purpose.</description><subject>Aged</subject><subject>Alzheimer Disease - diagnosis</subject><subject>Cornea - physiology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Mydriatics - pharmacology</subject><subject>Pupil - drug effects</subject><subject>Reproducibility of Results</subject><subject>Tropicamide - pharmacology</subject><issn>0042-6989</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMtLAzEYxHNQaq3-CYWcfBxWk83mdSylPqAgQj0v3yZfbGQfdbN7qH-9LRbnMjDzYw5DyJyzB864ekyMFXmmrLF3Vt0zxrnNzBmZ_scX5DKlL8aYlrmdkIllyhhhpuR9s0Xa7H0fYYiOYgjoBtoFOvTdLjpookcKradxSNRH-Gy7dATHhDS2dFH_bDE22N8e24SQ8IqcB6gTXp98Rj6eVpvlS7Z-e35dLtaZE1IMmYQAnBcKPCrHnZU8VMqqvMidwGDRVqA1ABZeABcIBZdaexEsK6SovBYzcvO3u-u77xHTUDYxOaxraLEbU6nNQdKIAzg_gWPVoC93fWyg35enD8QvFKRd4Q</recordid><startdate>199701</startdate><enddate>199701</enddate><creator>Reitner, A</creator><creator>Baumgartner, I</creator><creator>Thuile, C</creator><creator>Baradaran Dilmaghani, R</creator><creator>Ergun, E</creator><creator>Kaminski, S</creator><creator>Lukas, J</creator><creator>Dal Bianco, P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199701</creationdate><title>The mydriatic effect of tropicamide and its diagnostic use in Alzheimer's disease</title><author>Reitner, A ; Baumgartner, I ; Thuile, C ; Baradaran Dilmaghani, R ; Ergun, E ; Kaminski, S ; Lukas, J ; Dal Bianco, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-5afa1146ade6c1c951fb696242c3ef9e9ba77aae4d3a13ea41577d3f90453bd73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Aged</topic><topic>Alzheimer Disease - diagnosis</topic><topic>Cornea - physiology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Mydriatics - pharmacology</topic><topic>Pupil - drug effects</topic><topic>Reproducibility of Results</topic><topic>Tropicamide - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reitner, A</creatorcontrib><creatorcontrib>Baumgartner, I</creatorcontrib><creatorcontrib>Thuile, C</creatorcontrib><creatorcontrib>Baradaran Dilmaghani, R</creatorcontrib><creatorcontrib>Ergun, E</creatorcontrib><creatorcontrib>Kaminski, S</creatorcontrib><creatorcontrib>Lukas, J</creatorcontrib><creatorcontrib>Dal Bianco, P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Vision research (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reitner, A</au><au>Baumgartner, I</au><au>Thuile, C</au><au>Baradaran Dilmaghani, R</au><au>Ergun, E</au><au>Kaminski, S</au><au>Lukas, J</au><au>Dal Bianco, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The mydriatic effect of tropicamide and its diagnostic use in Alzheimer's disease</atitle><jtitle>Vision research (Oxford)</jtitle><addtitle>Vision Res</addtitle><date>1997-01</date><risdate>1997</risdate><volume>37</volume><issue>1</issue><spage>165</spage><epage>168</epage><pages>165-168</pages><issn>0042-6989</issn><abstract>The mydriatic effect of topically administered tropicamide was investigated as a possible diagnostic indicator for Alzheimer's disease. Although an initial series seemed to show a correlation between hypersensitivity to tropicamide and intellectual impairment, subsequent testing showed a greater inter- and intra-individual variation than that between the normal group and the group of patients with intellectual impairment. This procedure seems, therefore, to lack sufficient specificity to be useful for such a diagnostic purpose.</abstract><cop>England</cop><pmid>9068838</pmid><doi>10.1016/s0042-6989(96)00119-8</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0042-6989 |
| ispartof | Vision research (Oxford), 1997-01, Vol.37 (1), p.165-168 |
| issn | 0042-6989 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_78888583 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present); EZB-FREE-00999 freely available EZB journals |
| subjects | Aged Alzheimer Disease - diagnosis Cornea - physiology Female Humans Male Mydriatics - pharmacology Pupil - drug effects Reproducibility of Results Tropicamide - pharmacology |
| title | The mydriatic effect of tropicamide and its diagnostic use in Alzheimer's disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T23%3A45%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20mydriatic%20effect%20of%20tropicamide%20and%20its%20diagnostic%20use%20in%20Alzheimer's%20disease&rft.jtitle=Vision%20research%20(Oxford)&rft.au=Reitner,%20A&rft.date=1997-01&rft.volume=37&rft.issue=1&rft.spage=165&rft.epage=168&rft.pages=165-168&rft.issn=0042-6989&rft_id=info:doi/10.1016/s0042-6989(96)00119-8&rft_dat=%3Cproquest_pubme%3E78888583%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78888583&rft_id=info:pmid/9068838&rfr_iscdi=true |